<DOC>
	<DOCNO>NCT01782924</DOCNO>
	<brief_summary>This study design evaluate safety efficacy long-term exposure KHK4827 subject moderate severe plaque psoriasis complete precede Study 4827-002 .</brief_summary>
	<brief_title>A Phase 3 Clinical Study KHK4827</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subject voluntarily sign write informed consent form participate study Subject complete week 12 evaluation Study 4827002 Subject serious infection , define require systemic treatment antibiotic antiviral ( exclude oral administration ) Subject judge ineligible participation study investigators/subinvestigators</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>